Skip to main content

News

desc

Dr. Sofia Waldemarson was appointed Associate Professor (docent) in Immunotechnology at Lund University.    

desc

BioCARE, a center within the Swedish Research Council's effort to support strategic research areas, has been inaugurated. Prof. Carl Borrebaeck, the head of the Dept. of Immunotechnology, is one of 10 principal investigators active within this center. It will focus its activities to the field of biomarkers in cancer medicine.  

desc

Dr. Christer Wingren received a grant from Vinnova to develop a microchip technology platform for cancer diagnosis.  

desc

Rogosin Institute (New York, NY, USA) has signed an agreement with MAD for Cancer, a program headed by Prof. Carl Borrebaeck of the Dept. of Immuntechnology, to fund research Prof. Peter James of the Dept. of Immunotechnology.     

desc

The Department was granted support for a research project by the Swedish Cancer SocietySara Ek: Evaluation of Sox11 as therapeutic target in B cell lymphomas and analysis of its functional properties in malignant cells.

desc

Prof. Mats Ohlin was granted 2.5 MSEK by the Swedish Foundation for Strategic Research to support an industrial PhD student program entitled Target and antibody drug discovery in cancer in collaboration with BioInvent Int. AB.    

desc

The Department was granted support for two research projects by the Swedish Research Council:Doc. Sara Ek: Deciphering the molecular mechanisms of SOX11-related tumor growth.Prof. Mats Ohlin:  Human monoclonal IgE - addressing clinical aspects in allergy using molecular tools.   

desc

Dr. Malin Lindstedt and Prof. Carl Borrebaeck were awarded a grant from Vinnova for a project entitled "Utveckling av ny vaccinprincip baserad på intracellulär antigenfrisättning från nanopartiklar"  

desc

Prof. Mats Ohlin was granted support for a research project on the development of carbohydrate-specific probes by molecular engineering from the Swedish Research Council.

desc

A European FP7 research grant has been awarded to a consortium that includes Prof. Peter James of the Dept. of Immunotechnology. The reBIRTH (Brain Imaging Return To Health) consortium is a Marie Curie Initial Training Network that gathers experts on molecular mechanisms of age-associated pathologies including neurodegeneration and depression. The [...]

Page Manager: jana.hagman@immun.lth.se | 2022-11-21